Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Blood Cell Disorders”

412 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 412 results

Early research (Phase 1)Study completedNCT00684008
What this trial is testing

Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant

Who this might be right for
AMLCMLMDS
Cytheris, Inc. 12
Very early researchLooking for participantsNCT06045091
What this trial is testing

To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
Hrain Biotechnology Co., Ltd. 18
Not applicableStudy completedNCT01897987
What this trial is testing

Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial

Who this might be right for
Bronchopulmonary Dysplasia
Medipost Co Ltd. 62
Testing effectiveness (Phase 2)Study completedNCT04083534
What this trial is testing

First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Regeneron Pharmaceuticals 43
Not applicableStudy completedNCT02272530
What this trial is testing

Analysis of Proteome and Pathophysiological Characteristics of Human Blood Cells

Who this might be right for
Red Blood CellPeripheral Blood Mononuclear CellEndothelial NO-synthase
Heinrich-Heine University, Duesseldorf 200
Testing effectiveness (Phase 2)Ended earlyNCT01624701
What this trial is testing

Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells

Who this might be right for
Acute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more
Singapore General Hospital 3
Early research (Phase 1)Looking for participantsNCT05862012
What this trial is testing

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA 200
Early research (Phase 1)Active Not RecruitingNCT05753501
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Who this might be right for
Hematologic Cancer
AbbVie 135
Testing effectiveness (Phase 2)Study completedNCT02225665
What this trial is testing

Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART

Who this might be right for
Human Immunodeficiency Virus (HIV)
Sangamo Therapeutics 8
Early research (Phase 1)Study completedNCT03602612
What this trial is testing

T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma

Who this might be right for
Myeloma-MultipleMyeloma, Plasma-Cell
National Cancer Institute (NCI) 35
Large-scale testing (Phase 3)UnknownNCT01289106
What this trial is testing

Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects

Who this might be right for
HIV Infection
Chiang Mai University 132
Large-scale testing (Phase 3)Study completedNCT00270114
What this trial is testing

The Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)

Who this might be right for
AnemiaBlood TransfusionOrthopedic Procedures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 55
Early research (Phase 1)Study completedNCT00000849
What this trial is testing

Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 27
Post-approval studies (Phase 4)Study completedNCT04192487
What this trial is testing

Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

Who this might be right for
Acquired Immunodeficiency SyndromeHealthy VolunteersHIV/AIDS+2 more
Napo Pharmaceuticals, Inc. 17
Early research (Phase 1)WithdrawnNCT03531281
What this trial is testing

Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHematopoietic Cell Transplantation Recipient
City of Hope Medical Center
Not applicableStudy completedNCT02294487
What this trial is testing

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaMyeloma, MultipleMyeloma-Multiple
Wake Forest University Health Sciences 19
Early research (Phase 1)Study completedNCT01217359
What this trial is testing

Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling

Who this might be right for
Hepatitis C
University of North Carolina, Chapel Hill 22
Large-scale testing (Phase 3)Study completedNCT00169442
What this trial is testing

Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants

Who this might be right for
Whole Cell PertussisDiphtheriaHepatitis B+2 more
GlaxoSmithKline 745
Not applicableLooking for participantsNCT07266142
What this trial is testing

Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker

Who this might be right for
Skin Cancer, Non-MelanomaSkin Cancer Melanoma
Universitaire Ziekenhuizen KU Leuven 7,500
Testing effectiveness (Phase 2)Ended earlyNCT04735575
What this trial is testing

A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Shanghai EpimAb Biotherapeutics Co., Ltd. 40
Next Page